June 9, 2010 – Boston, MA & San Diego, CA— PHT Corporation, the leading provider of electronic patient reported outcome (ePRO) solutions today announced a strategic partnership with Entra Health Systems, an international applied healthcare technology company. Together PHT and Entra Health will provide integrated data monitoring technology for the management of clinical trials for the treatment of diabetes and in trials where blood glucose management plays a critical role in the investigation.

This unique solution for clinical trials combines Entra Health’s MyGlucoHealth Wireless blood glucose meter with PHT’s ePRO System to create an automated glucose monitoring and ePRO solution.

“It comes down to hard data versus soft data.” said Richard Strobridge, CEO of Entra Health Systems. “Clinical Investigators now have direct access to real-time blood glucose data during clinical trials. Patient-related inaccuracies are eliminated. With the MyGlucoHealth Wireless meter we can monitor in real-time not just blood glucose readings, but when and how often patients are testing. Also, MyGlucoHealth offers a higher level of accuracy along with the unique ability to wirelessly upload readings using Bluetooth.”

“Our goal in launching this solution is to capture time-sensitive data, directly from the patient,” said Phil Lee, President and CEO of PHT. “Research studies have shown hand-written paper log book entries of glucose data contain numerous errors both in transcription and time accuracy. Waiting, downloading, or transcribing this critical data lead to delays and poor clinical trial data quality. Sponsors demand the most accurate real-time data to monitor patient status and evaluate compliance and study effectiveness.. The PHT and MyGlucoHealth partnership brings a new level of sophistication to clinical trials that capture blood glucose information.”

The integration between PHT’s handheld technology and the MyGlucoHealth’s Wireless glucometer provides maximum ease of use for patients while improving data flow and ensuring participation and compliance. The system improves safety and rewards researchers with more accurate, real-time data from every clinical trials patient, every day.

About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions that have been used in more than 400 clinical trials by over 100 biopharmaceutical clients. Its proven LogPad® System and versatile SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 12 NDA submissions and eight approvals to date.

For more information, review the interactive product demonstrations at PHT’s award-winning www.phtcorp.com site. Visit PHT at the 46th DIA Annual Meeting in Booth 644.

PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are regis

About MyGlucoHealth® & Entra Health Systems
The MyGlucoHealth Wireless meter, developed by Entra Health Systems, is the first and only FDA cleared and CE certified Bluetooth®-enabled glucometer of its kind in the world. MyGlucoHealth works in combination with a real-time online data collection network to securely upload and manage blood glucose readings using a mobile phone or PC eliminating the need to maintain personal logbooks.

Using automated tools, MyGlucoHealth can set up reminders to encourage patients to test more frequently, as well as to notify family, caregivers and clinicians when testing results fluctuate. The meter, along with the MyGlucoHealth Network, form an integrated telehealth platform supporting patients and healthcare professionals in the control and treatment of diabetes. MyGlucoHealth gives patients more

direct control over their care and provides clear lines of communication with clinicians and caregivers.
Entra Health Systems designs and manufactures technologies that enhance patient care while at the same time reducing the burden on healthcare providers. Headquartered in San Diego, with offices in Australia and the United Kingdom, Entra Health’s products and services are engineered to improve communication between the patient, clinician and caregiver. For more information visit: www.entrahealthsystems.com, or www.myglucohealth.net.

Media Contacts
Bruce Ahern, Chief Marketing Officer
Entra Health Systems
877-458-2646 Extension 708

Contact: Brenda Nashawaty
PHT Corporation